ARTICLE | Company News

Chiron, Baxter infectious news

February 27, 2006 8:00 AM UTC

The U.K. Department of Health issued CHIR and BAX contracts worth a total of £33 million ($57.5 million) to supply about 3.5 million doses of H5N1 avian influenza vaccine. BAX said its contract is worth about $20 million and that it will supply two million doses of its vaccine. CHIR would not disclose further details about its contract. ...